Markers of inflammation: data from the MOSAIC randomised trial of CPAP for minimally symptomatic OSA.
Thorax
; 70(2): 181-2, 2015 Feb.
Article
en En
| MEDLINE
| ID: mdl-25182045
ABSTRACT
UNLABELLED The Multi-centre Obstructive Sleep Apnoea Interventional Cardiovascular (MOSAIC) trial compared 6â
months of CPAP therapy, versus no CPAP, in 391 patients with minimally symptomatic obstructive sleep apnoea (OSA). We now report some exploratory outcomes, markers of systemic inflammation (interleukin 6 (IL-6), IL-10, C reactive protein, tumour necrosis factor). We found no consistent changes (all p values >0.13). TRIAL REGISTRATION NUMBER ISRCTN 34164388.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Proteína C-Reactiva
/
Interleucina-6
/
Factor de Necrosis Tumoral alfa
/
Interleucina-10
/
Apnea Obstructiva del Sueño
/
Inflamación
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Etiology_studies
Límite:
Humans
Idioma:
En
Revista:
Thorax
Año:
2015
Tipo del documento:
Article
País de afiliación:
Reino Unido